Successful antihypertensive treatment using sacubitril/valsartan alone in a patient with obstructive sleep apnoea syndrome

Obstructive sleep apnoea syndrome (O-SAS) induces excessive activity of the sympathetic nervous system, resulting in secondary hypertension. Although continuous positive airway pressure (CPAP) is the first-line therapy for O-SAS, poor adherence to CPAP induces uncontrollable resistant hypertension....

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ryuta Sugihara, Yuusaku Sugihara, Itsuko Sugihara, Yasushi Sakata
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier España 2023-10-01
Saila:	Medicina Clínica Práctica
Gaiak:	síndrome de apnea obstructiva del sueño hipertensión sacubitril/valsartán
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2603924923000319
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!